Apeiron Investment Group amends Bionomics stake filing

TL;DR

Apeiron Investment Group just updated its Bionomics filing, adding new players to the group. Watch this space.

AI Summary

Apeiron Investment Group Ltd. filed an amendment (No. 1) to its Schedule 13D on October 7, 2024, regarding its holdings in Bionomics Limited. The filing indicates a change in the group members associated with Apeiron, including Christian Angermayer and Fabian Hansen, and the addition of Presight Capital Management I, L.L.C. and Apeiron Presight Capital Fund II, L.P. as group members.

Why It Matters

This amendment signals a potential shift in the control or influence dynamics for Bionomics Limited, as new entities and individuals are disclosed as part of the reporting group.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings can indicate changes in investment strategy or potential activism, which may introduce uncertainty for the subject company.

Key Players & Entities

• Apeiron Investment Group Ltd. (company) — Filing entity
• Bionomics Limited (company) — Subject company
• Christian Angermayer (person) — Group member
• Fabian Hansen (person) — Group member
• Presight Capital Management I, L.L.C. (company) — Group member
• Apeiron Presight Capital Fund II, L.P. (company) — Group member
• Julien Höfer (person) — Authorized to receive notices

FAQ

Filing Documents

• d900253dsc13da.htm (SC 13D/A) — 100KB
• 0001193125-24-233941.txt ( ) — 101KB

of the Schedule 13D is hereby amended and restated in its entirety as follows

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: (a) (b) The following sets forth, as of the date of this Schedule 13D, the aggregate number of Ordinary Shares and percentage of Ordinary Shares beneficially owned by each of the Reporting Persons, as well as the number of Ordinary Shares as to which each Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition of, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 3,117,662,864 Ordinary Shares outstanding as of September 17, 2024 as reported by the Issuer on its Annual Report on Form 10-K filed on September 30, 2024. Reporting Person Amount beneficially owned Percent of class Sole power to vote or to direct the vote Shared power to vote or to direct the vote Sole power to dispose or to direct the disposition Shared power to dispose or to direct the disposition Apeiron Investment Group, Ltd. 276,490,501 8.9 % 0 276,490,501 0 276,490,501 Apeiron Presight Capital Fund II, L.P. 93,369,060 3.0 % 0 93,369,060 0 93,369,060 Presight Capital Management I, L.L.C. 93,369,060 3.0 % 0 93,369,060 0 93,369,060 Fabian Hansen 93,369,060 3.0 % 0 93,369,060 0 93,369,060 Christian Angermayer 276,490,501 8.9 % 0 276,490,501 0 276,490,501 Presight II is the record holder of 518,717 ADSs representing 93,369,060 Ordinary Shares. Apeiron and Fabian Hansen are the managing members of Presight Management, which is the general partner of Presight II. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities held by Presight II. In addition, Apeiron is the record holder of 146,279 ADSs (representing 26,330,220 Ordinary Shares) and 156,791,221 Ordinary Shares. Christian Angermayer is the majority sharehol

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : October 7, 2024 Apeiron Investment Group, Ltd. By: /s/ Mario Frendo Name: Mario Frendo Title: Director Apeiron Presight Capital Fund II, L.P. By:Presight Capital Management I, L.L.C., its general partner By: /s/ Fabian Hansen Name: Fabian Hansen Title: Managing Member Presight Capital Management I, L.L.C. By: /s/ Fabian Hansen Name: Fabian Hansen Title: Managing Member Fabian Hansen /s/ Fabian Hansen Christian Angermayer /s/ Christian Angermayer

View Full Filing

View this SC 13D/A filing on SEC EDGAR